Teladoc Slides 2.38% as Quarterly Earnings Estimates Approach
The telehealth provider fell more than the S&P 500, while Zacks' next-quarter estimates point to lower earnings and revenue.
Teladoc Health shares fell 2.38% to close at $5.75 in the latest session, underperforming the S&P 500, which lost 0.17%. The telehealth provider also trailed the Dow and Nasdaq, which fell 0.26% and 0.09%, respectively.
Over the past month, Teladoc's stock has fallen 7.1%. The Medical sector declined 0.67% over the same period, while the S&P 500 slipped 0.24%.
Investors are awaiting the company's next earnings release. Zacks' consensus estimate calls for a quarterly loss of 23 cents per share, down 9.52% year over year, and revenue of $585.55 million, a 6.53% decline.
For the full year, Zacks' consensus forecast is earnings of -$0.92 per share and revenue of $2.4 billion. The estimates imply a 19.3% year-over-year increase in earnings and a 5.03% drop in revenue.
The consensus estimate for earnings per share has fallen 1.62% over the past 30 days, according to Zacks.
This article was produced with the help of AI technology.
Source: Yahoo Finance
